Renaissance Tech Amends USANA Health Sciences Stake
Ticker: USNA · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 896264
| Field | Detail |
|---|---|
| Company | Usana Health Sciences Inc (USNA) |
| Form Type | SC 13G/A |
| Filed Date | Feb 13, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, health-sciences
TL;DR
**Renaissance Technologies still owns USANA stock, signaling continued institutional interest.**
AI Summary
Renaissance Technologies LLC, a major investment firm, filed an amendment to their SC 13G, indicating their ownership in USANA Health Sciences Inc. as of December 29, 2023. This filing, an Amendment No. 9, shows that Renaissance Technologies continues to hold a significant stake in USANA, a company specializing in medicinal chemicals and botanical products. For investors, this signals that a sophisticated institutional investor maintains confidence in USANA, which could be a positive indicator for the stock's stability or future performance.
Why It Matters
This filing shows that a major institutional investor, Renaissance Technologies, continues to hold a significant position in USANA Health Sciences, which can be seen as a vote of confidence in the company's prospects.
Risk Assessment
Risk Level: low — This filing is a routine update from an institutional investor and does not indicate any immediate negative risks for the stock.
Analyst Insight
Investors should note that a major institutional investor like Renaissance Technologies continues to hold USANA stock, which might warrant further research into USANA's fundamentals and future prospects.
Key Players & Entities
- Renaissance Technologies LLC (company) — the investment firm filing the SC 13G/A
- USANA Health Sciences Inc. (company) — the subject company whose shares are being reported
- December 29, 2023 (date) — the date of the event requiring the filing
- Amendment No. 9 (number) — the specific amendment number of the filing
Forward-Looking Statements
- Renaissance Technologies will maintain a significant stake in USANA Health Sciences for the foreseeable future. (Renaissance Technologies LLC) — medium confidence, target: 2024-12-31
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and '(Amendment No. 9)*'.
Who is the subject company of this filing?
The subject company is USANA HEALTH SCIENCES, INC., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC'.
Who filed this SC 13G/A?
The filing was made by RENAISSANCE TECHNOLOGIES LLC, as indicated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RENAISSANCE TECHNOLOGIES LLC'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 29, 2023, as specified under '(Date of Event Which Requires Filing of this Statement)'.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by '[X] Rule 13d-1(b)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 13, 2024 regarding USANA HEALTH SCIENCES INC (USNA).